Stock Comparison
ARGX vs GMAB
argenx NV ADR and Genmab AS side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$53.23B
$19.78B
P/E (TTM)
32.7
25.0
Forward P/E
30.4
18.4
Price/Sales
10.0
4.8
Price/Book
6.4
3.3
EV/EBITDA
27.6
18.3
Dividend Yield
—
—
Profitability
Net Margin
30.44%
21.05%
Operating Margin
27.34%
32.99%
Return on Equity
23.60%
14.00%
Return on Assets
11.60%
8.79%
Growth (YoY)
Revenue Growth
59.30%
24.90%
Earnings Growth
95.20%
-9.40%
Price & Risk
Beta
-0.0
0.7
52-Week High
$939.68
$35.34
52-Week Low
$652.43
$22.98
Analyst Target
$1,085.78
$38.46
Compare ARGX and GMAB your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.